多发性骨髓瘤微小残留病检测:MSKCC 10色单管法与EuroFlow 8色双管法的比较
研究对41例多发性骨髓瘤患者的骨髓样本平行采用MSKCC 10色单管法与EuroFlow 8色双管法检测微小残留病,两法总体一致率为98%,异常浆细胞测量高度一致(r²=0.97),但MSKCC单管法总细胞数略低(平均比值0.85,P<.05),1例在检测限附近出现差异。
要点
- 两法总体一致率98%,异常浆细胞测量高度一致(r²=0.97)。
- MSKCC单管法总细胞数平均为EuroFlow双管法之和的0.85倍(范围0.57-1.46,P<.05)。
- 1例在检测限附近出现差异,倾向于EuroFlow双管法理论灵敏度略高。
核心结论
- MSKCC 10色单管法与EuroFlow 8色双管法在检测多发性骨髓瘤微小残留病方面总体一致率为98%,异常浆细胞测量高度一致。
研究设计与样本
- 对41例多发性骨髓瘤患者的骨髓样本平行采用MSKCC 10色单管法和EuroFlow 8色双管法进行微小残留病检测。
主要发现
- MSKCC单管法总细胞数较EuroFlow两管8色法之和略有减少,平均比值0.85(范围0.57-1.46;P<.05),可能归因于细胞透化处理。
- 浆细胞百分比高度一致(r²=0.97),正常浆细胞亦高度一致(r²=0.96),提示无选择性浆细胞丢失。
- 异常浆细胞测量的残留病负荷高度一致(r²=0.97)。
- 两法总体一致率为98%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In patients with multiple myeloma, obtaining posttreatment minimal residual disease (MRD) negativity is associated with longer progression-free survival and overall survival. Here, we compared the diagnostic performance of a single 10-color tube with that of a EuroFlow 8-color 2-tube panel for MRD testing. Bone marrow samples from 41 multiple myeloma patients were tested in parallel using the 2 approaches. Compared with the sum of the cells from the EuroFlow two 8-color tubes, the Memorial Sloan Kettering Cancer Center (MSKCC) single 10-color tube had a slight reduction in total cell number with a mean ratio of 0.85 (range, 0.57-1.46; P < .05), likely attributable to permeabilization of the cells. Percent of plasma cells showed a high degree of concordance (r2 = 0.97) as did normal plasma cells (r2 = 0.96), consistent with no selective plasma cell loss. Importantly, concordant measurement of residual disease burden was seen with abnormal plasma cells (r2 = 0.97). The overall concordance between the 2 tests was 98%. In 1 case, there was a discrepancy near the limit of detection of both tests in favor of the slightly greater theoretical sensitivity of the EuroFlow 8-color 2-tube panel (analytical sensitivity limit of MSKCC single 10-color tube: 6 cells in 1 million with at least 3 million cell acquisitions; EuroFlow 8-color 2-tube panel: 2 cells in 1 million with the recommended 10 million cell acquisitions).
引用
- Roshal M, Flores-Montero JA, Gao Q, et al. MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods. Blood Adv. 2017. PMID: 29296716. doi:10.1182/bloodadvances.2016003715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。